Overview
Paul Seligman is a Hematologist and a Hematologist Oncology provider in Aurora, Colorado. Dr. Seligman is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. His top area of expertise is Neuroblastoma.
His clinical research consists of co-authoring 5 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Neuroblastoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Denver Health And Hospital Authority
Sandhya Sharma is a Hematologist Oncology specialist and a Hematologist in Denver, Colorado. Dr. Sharma is rated as an Advanced provider by MediFind in the treatment of Neuroblastoma. Her top areas of expertise are Mononucleosis, Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, and Graft Versus Host Disease (GvHD).
Rocky Mountain Cancer Centers Llp
Ling Ma is a Hematologist Oncology specialist and a Hematologist in Thornton, Colorado. Dr. Ma is rated as a Distinguished provider by MediFind in the treatment of Neuroblastoma. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Agranulocytosis, and Chronic Familial Neutropenia.
Rocky Mountain Cancer Centers Llp
Manojkumar Bupathi is a Hematologist Oncology specialist and an Oncologist in Littleton, Colorado. Dr. Bupathi is rated as a Distinguished provider by MediFind in the treatment of Neuroblastoma. His top areas of expertise are Urothelial Cancer, Breast Cancer, Paget Disease of the Breast, and Chromophobe Renal Cell Carcinoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers